NovaBay Pharmaceuticals, Inc. Financing cash flow

Financing cash flow of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Financing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Financing cash flow for the quarter ending June 30, 2022 was $-117 Thousand (a -106.37% decrease compared to previous quarter)
  • Year-over-year quarterly Financing cash flow decreased by -204.46%
  • Annual Financing cash flow for 2021 was $16.7 Million (a 86.8% increase from previous year)
  • Annual Financing cash flow for 2020 was $8.96 Million (a -17.69% decrease from previous year)
  • Annual Financing cash flow for 2019 was $10.9 Million (a 94.43% increase from previous year)
  • Twelve month Financing cash flow ending June 30, 2022 was $16.9 Million (a -9.59% decrease compared to previous quarter)
  • Twelve month trailing Financing cash flow increased by 897.4% year-over-year
Trailing Financing cash flow for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$16.9 Million $18.7 Million $16.7 Million $1.69 Million
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Financing cash flow of NovaBay Pharmaceuticals, Inc.

Most recent Financing cash flowof NBY including historical data for past 10 years.

Interactive Chart of Financing cash flow of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.12 $1.84
2021 $15.05 $0.11 $1.67 $-0.1 $16.73
2020 $0.01 $6.01 $4.11 $-0.36 $8.96
2019 $-0.65 $6.85 $2.52 $2.98 $10.88
2018 $0.0 $0.0 $-0.01 $5.6 $5.6
2017 $0.07 $0.15 $0.04 $-0.05 $0.2
2016 $0.86 $9.82 $4.75 $3.99 $19.42
2015 $3.57 $0.34 $7.04 $4.65 $15.6
2014 $0.42 $0.36 $0.05 $6.56 $7.39
2013 $7.02 $1.83 $0.45 $0.03 $9.33
2012 $8.19 $1.31 $0.01 $-0.04 $9.47
2011 $0.12 $4.7

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology